BBC·3 min read·medium
First person gets new experimental vaccine for Bundibugyo species of Ebola
✦AI Summary
The first human volunteer has received an experimental vaccine targeting the Bundibugyo species of Ebola, developed by researchers at the University of Oxford. This phase one trial aims to assess the safety and immune response of the vaccine, which uses technology similar to the Oxford-AstraZeneca Covid jab.
Share Save Add as preferred on Google Fergus Walsh Medical editor BBC Ed Hunt receiving the Ebola vaccine in Oxford The first volunteer in the world - a 37-year-old UK man called Ed Hunt - has received an experimental vaccine against the Ebola virus.
healthscience
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in